Home > Healthcare IT > Tuberculosis Testing Market Information by Diagnostic Test Type, End User and Regional Out
Straits Research

Tuberculosis Testing Market

Tuberculosis Testing Market: Information by Diagnostic Test Type (Radiographic Test, Nucleic Acid Testing), End User (Hospital, Clinic, Diagnostics) and, Regional Outlook—Forecast Till 2026

Table of Content Download Sample

Market Snapshot

market snapshot
Base Year:
2017
Study Period:
2016–2026
CAGR:
4.1 %
Fastest Growing Market:
Asia-Pacific
Largest Market:
North America

Global Statistics Representing Tuberculosis Testing Market Scenario

Tuberculosis is fatal disease caused by bacteria of genus mycobacteria. It mainly targets lungs but bacteria can attack on other body parts as well and cause infection of genitourinary system, lymphatic system and central nervous system. Pulmonary tuberculosis is bacterial infection in lungs while infection in other body parts is extra pulmonary tuberculosis.

For TB detection two main methods are preferred rapid method and routine method. Routine method is prominently and widely preferred including skin test. As per of Centre for disease control and prevention around 9,105 TB cases around (2.8 cases per 100,000 persons) were suffering from TB in 2017. In 2017 only total 1,600,000 deaths were reported due to TB. After this increasing number of the TB patients all over the world the demand of diagnosing kit or testing kits for TB is also increasing.

Global tuberculosis (TB) testing market was valued at around USD 1200 million in 2017 and is expected to grow at a CAGR of 4.1% during the forecast period

Intended Audience

  • Healthcare Institutions (Hospitals and Surgical Centers)
  • Pharmaceutical Companies
  • Biotechnological companies
  • Academic institutes
  • Potential Investors
  • Research and Development Institutes

Market Segmentation

The global tuberculosis testing market can be segmented by diagnostic test type and end user.

On the basis of diagnostic test type, the tuberculosis testing market can be segmented into radiographic test, laboratory test, nucleic acid testing, cytokine detection test, drug resistance test, and other diagnostic test types. The laboratory test segment is expected to account for a significant market share during the forecast period.

Based on end user, the market can be segmented into hospital/clinic and diagnostics/research. Among the two, the diagnostics and research segment is expected to lead the market during the forecast period.

Regional Analysis

Geographically, the global tuberculosis testing market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (LAMEA).

North America is projected to account for the largest share of the global tuberculosis testing market during the forecast period, 2019–2026. The weakening of the immunity system, due to chronic diseases such as HIV is an important cause of tuberculosis. According to the National Aids Control Organisation, in 2015, approximately 1.1 million people suffered from HIV in the U.S. This prevalence of HIV has directly been leading to an increase in the incidences of tuberculosis, which, in turn, drives market growth.

Europe accounts for a significant share of the global tuberculosis testing market, owing to the region’s expanding geriatric population who are prone to chronic diseases. Moreover, the prominent presence of key players in the region further supports market growth.

Asia-Pacific is pegged to be the fastest growing market during the forecast period. In India, government support and early diagnosis of tuberculosis are among the key factors propelling market growth. The Indian government organizes various campaigns to raise awareness regarding tuberculosis, which in turn provides impetus to market growth.

The LAMEA region is expected to witness substantial growth in the global market during the forecast period, owing to the increasing prevalence of tuberculosis and infrastructure improvement in the region.

Key Players

Some of the key players in the tuberculosis testing market include Abbott Laboratories, Becton Dickinson & Company, BioMerieux SA, Cepheid, F. Hoffmann-La Roche AG, Hain LifeScience GmbH, Hologic Corporation, Qiagen, AdvaCare Pharma, and Thermo Fischer Scientific Inc.

Report Scope

Report Metric Details
Market Size USD 1200 million in 2017
CAGR CAGR 4.1%
Historical Data 2015-2016
Base Year 2017
Forecast Period 2018-2026
Forecast Units Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered by Diagnostic Test Type (Radiographic Test, Nucleic Acid Testing), End User (Hospital, Clinic, Diagnostics) and
Geographies Covered North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors Abbott Laboratories, Becton Dickinson & Company, BioMerieux SA, Cepheid, F. Hoffmann-La Roche AG, Hain LifeScience GmbH, Hologic Corporation, Qiagen, AdvaCare Pharma, and Thermo Fischer Scientific Inc.,
Key Market Opportunities Rapid Growth In Healthcare It Industry Enhances Tuberculosis Testing Market

Tuberculosis Testing Market Segmentation

By Diagnostic Test Type

  • Radiographic Test
  • Laboratory Test
    • Smear Microscopy
    • Culture-Based Test
  • Nucleic Acid Test
  • Cytokine Detection Test
  • Drug Resistance Test
  • Other Diagnostic Test Types

By End User

  • Hospital/Clinic
  • Diagnostics/Research

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America and Middle East & Africa

Why Buy This Report?

This report offers key insights pertaining to the tuberculosis testing market with an emphasis on recent developments across geographies and development strategies adopted by prominent market participants. The following sections have specifically been covered in the report.

  • Definitive Market Data
  • Tuberculosis Testing Market Analysis
  • Competitive Analysis
  • Recent Opportunities in the Market
  • 6-7 Year Performance Forecasts: Major Segments by Disease Type and Therapy
  • Market Share Analysis
  • Potential Venture Avenues
Price Starts From
USD4250

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report
Want to learn more about recent trends and data ?
They Already Trust Us :
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Johnson & Johnson
Need Assistance?
+1 646 480 7505 (U.S.)
+44 208 068 9665 (U.K.)
Looking For Custom Report ?

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track sales in the global and country-specific Market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Check Our License Options :
Report Snapshot

As featured on :

clients
Trusted by Fortune 500
Over 30000+ subscribers